Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

April 01, 1996; Volume 49,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anyanwutaku, I O

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;
  2. Arrighi, V

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;
  3. Ashford, M L

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;

B

  1. Ballyk, B

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  2. Barnes, P J

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  3. Beindl, W

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  4. Blackmore, P F

    1. You have access
      Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
      P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale
      Molecular Pharmacology April 1996, 49 (4) 727-739;
  5. Bleakman, R

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  6. Bleasdale, J E

    1. You have access
      Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
      P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale
      Molecular Pharmacology April 1996, 49 (4) 727-739;
  7. Boehm, S

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  8. Bouvier, M

    1. You have access
      Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
      G Rousseau, F Nantel and M Bouvier
      Molecular Pharmacology April 1996, 49 (4) 752-760;
  9. Buell, G

    1. You have access
      D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
      P Werner, N Hussy, G Buell, K A Jones and R A North
      Molecular Pharmacology April 1996, 49 (4) 656-661;
  10. Bufton, H

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;

C

  1. Chen, H X

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;
  2. Chen, J

    1. You have access
      Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
      J A Javitch, D Fu and J Chen
      Molecular Pharmacology April 1996, 49 (4) 692-698;
  3. Cheng, Y C

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;
  4. Consolandi, O

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;

D

  1. Dahlman-Wright, K

    1. You have access
      Modulation of glucocorticoid-inducible gene expression by metal ions.
      Y Makino, H Tanaka, K Dahlman-Wright and I Makino
      Molecular Pharmacology April 1996, 49 (4) 612-620;

E

  1. Eidne, K A

    1. You have access
      Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
      P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
      Molecular Pharmacology April 1996, 49 (4) 646-655;
  2. Ernsberger, P

    1. You have access
      Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
      D Separovic, M Kester and P Ernsberger
      Molecular Pharmacology April 1996, 49 (4) 668-675;

F

  1. Fisher, J F

    1. You have access
      Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
      P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale
      Molecular Pharmacology April 1996, 49 (4) 727-739;
  2. Freissmuth, M

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  3. Fu, D

    1. You have access
      Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
      J A Javitch, D Fu and J Chen
      Molecular Pharmacology April 1996, 49 (4) 692-698;
  4. Fumagalli, F

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;

G

  1. Galli, P

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;
  2. Giembycz, M A

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  3. Glashofer, M

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
  4. Gosselin, G

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;
  5. Grassie, M A

    1. You have access
      Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
      P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
      Molecular Pharmacology April 1996, 49 (4) 646-655;
  6. Guo, X

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;

H

  1. Haddad, E B

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  2. Hales, C N

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  3. Hall, A C

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  4. Hohenegger, M

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  5. Houghton, P J

    1. You have access
      Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
      L L Shu and P J Houghton
      Molecular Pharmacology April 1996, 49 (4) 595-601;
  6. Hussy, N

    1. You have access
      D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
      P Werner, N Hussy, G Buell, K A Jones and R A North
      Molecular Pharmacology April 1996, 49 (4) 656-661;

I

  1. Ijzerman, A P

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  2. Ikeda, S R

    1. You have access
      Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
      X Pan, S R Ikeda and D L Lewis
      Molecular Pharmacology April 1996, 49 (4) 707-714;
  3. Imbach, J L

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;

J

  1. Jacobson, K A

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
  2. Javitch, J A

    1. You have access
      Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
      J A Javitch, D Fu and J Chen
      Molecular Pharmacology April 1996, 49 (4) 692-698;
  3. Ji, Z

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;
  4. Jiang, Q

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
  5. Jones, K A

    1. You have access
      D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
      P Werner, N Hussy, G Buell, K A Jones and R A North
      Molecular Pharmacology April 1996, 49 (4) 656-661;
  6. Jones, S V

    1. You have access
      Modulation of the inwardly rectifying potassium channel IRK1 by the m1 muscarinic receptor.
      S V Jones
      Molecular Pharmacology April 1996, 49 (4) 662-667;

K

  1. Kamboj, R K

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  2. Kester, M

    1. You have access
      Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
      D Separovic, M Kester and P Ernsberger
      Molecular Pharmacology April 1996, 49 (4) 668-675;
  3. Khan, R N

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  4. Kim, G D

    1. You have access
      Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
      P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
      Molecular Pharmacology April 1996, 49 (4) 646-655;
  5. Kim, J

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
  6. Kimmett, S M

    1. You have access
      Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology April 1996, 49 (4) 676-682;

L

  1. Lee, K

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  2. Lee, K H

    1. You have access
      Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
      I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng
      Molecular Pharmacology April 1996, 49 (4) 721-726;
  3. Lewis, D L

    1. You have access
      Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
      X Pan, S R Ikeda and D L Lewis
      Molecular Pharmacology April 1996, 49 (4) 707-714;
  4. Lovati, E

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;

M

  1. Mak, J C

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  2. Makino, I

    1. You have access
      Modulation of glucocorticoid-inducible gene expression by metal ions.
      Y Makino, H Tanaka, K Dahlman-Wright and I Makino
      Molecular Pharmacology April 1996, 49 (4) 612-620;
  3. Makino, Y

    1. You have access
      Modulation of glucocorticoid-inducible gene expression by metal ions.
      Y Makino, H Tanaka, K Dahlman-Wright and I Makino
      Molecular Pharmacology April 1996, 49 (4) 612-620;
  4. Marks, G S

    1. You have access
      Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology April 1996, 49 (4) 676-682;
  5. Mazumder, A

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;
  6. Memo, M

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;
  7. Milligan, G

    1. You have access
      Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
      P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
      Molecular Pharmacology April 1996, 49 (4) 646-655;
  8. Molteni, R

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;

N

  1. Nanoff, C

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  2. Nantel, F

    1. You have access
      Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
      G Rousseau, F Nantel and M Bouvier
      Molecular Pharmacology April 1996, 49 (4) 752-760;
  3. Neamati, N

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;
  4. Nestler, E J

    1. You have access
      Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
      H E Nye and E J Nestler
      Molecular Pharmacology April 1996, 49 (4) 636-645;
  5. Nickel, P

    1. You have access
      Suramin analogues as subtype-selective G protein inhibitors.
      M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff
      Molecular Pharmacology April 1996, 49 (4) 602-611;
  6. North, R A

    1. You have access
      D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
      P Werner, N Hussy, G Buell, K A Jones and R A North
      Molecular Pharmacology April 1996, 49 (4) 656-661;
  7. Nye, H E

    1. You have access
      Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
      H E Nye and E J Nestler
      Molecular Pharmacology April 1996, 49 (4) 636-645;

O

  1. Ornstein, P L

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  2. Ozanne, S E

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;

P

  1. Pan, X

    1. You have access
      Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
      X Pan, S R Ikeda and D L Lewis
      Molecular Pharmacology April 1996, 49 (4) 707-714;
  2. Papadakis, E

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  3. Pessah, I N

    1. You have access
      Ortho-substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type microsomal calcium release channels.
      P W Wong and I N Pessah
      Molecular Pharmacology April 1996, 49 (4) 740-751;
  4. Pizzi, M

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;
  5. Pommier, Y

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;

R

  1. Racagni, G

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;
  2. Riva, M A

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;
  3. Rousell, J

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  4. Rousseau, G

    1. You have access
      Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
      G Rousseau, F Nantel and M Bouvier
      Molecular Pharmacology April 1996, 49 (4) 752-760;
  5. Rowe, I C

    1. You have access
      Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
      K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford
      Molecular Pharmacology April 1996, 49 (4) 715-720;
  6. Rusnati, M

    1. You have access
      Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
      M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni
      Molecular Pharmacology April 1996, 49 (4) 699-706;

S

  1. Schinazi, R F

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;
  2. Schoepp, D D

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  3. Separovic, D

    1. You have access
      Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
      D Separovic, M Kester and P Ernsberger
      Molecular Pharmacology April 1996, 49 (4) 668-675;
  4. Sharpe, E F

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;
  5. Shu, L L

    1. You have access
      Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
      L L Shu and P J Houghton
      Molecular Pharmacology April 1996, 49 (4) 595-601;
  6. Sommadossi, J P

    1. You have access
      Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
      A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier
      Molecular Pharmacology April 1996, 49 (4) 621-628;
  7. Spano, P F

    1. You have access
      Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
      M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano
      Molecular Pharmacology April 1996, 49 (4) 586-594;
  8. Spilman, C H

    1. You have access
      Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
      P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale
      Molecular Pharmacology April 1996, 49 (4) 727-739;
  9. Svoboda, P

    1. You have access
      Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
      P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan
      Molecular Pharmacology April 1996, 49 (4) 646-655;

T

  1. Tanaka, H

    1. You have access
      Modulation of glucocorticoid-inducible gene expression by metal ions.
      Y Makino, H Tanaka, K Dahlman-Wright and I Makino
      Molecular Pharmacology April 1996, 49 (4) 612-620;
  2. Thomas, K

    1. You have access
      Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
      R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj
      Molecular Pharmacology April 1996, 49 (4) 581-585;

W

  1. Webb, B L

    1. You have access
      Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
      J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes
      Molecular Pharmacology April 1996, 49 (4) 629-635;
  2. Werner, P

    1. You have access
      D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
      P Werner, N Hussy, G Buell, K A Jones and R A North
      Molecular Pharmacology April 1996, 49 (4) 656-661;
  3. Wess, J

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
  4. Whitney, R A

    1. You have access
      Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
      S M Kimmett, R A Whitney and G S Marks
      Molecular Pharmacology April 1996, 49 (4) 676-682;
  5. Wong, P W

    1. You have access
      Ortho-substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type microsomal calcium release channels.
      P W Wong and I N Pessah
      Molecular Pharmacology April 1996, 49 (4) 740-751;

Y

  1. Yehle, S

    1. You have access
      Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
      J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson
      Molecular Pharmacology April 1996, 49 (4) 683-691;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 49, Issue 4
1 Apr 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics